<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The pathophysiology of <z:hpo ids='HP_0001650'>aortic stenosis</z:hpo> is incompletely understood, and the relative contributions of valvular calcification and <z:mp ids='MP_0001845'>inflammation</z:mp> to disease progression are unknown </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS AND RESULTS: Patients with aortic <z:mp ids='MP_0000612'>sclerosis</z:mp> and mild, moderate, and severe stenosis were compared prospectively with age- and sex-matched control subjects </plain></SENT>
<SENT sid="2" pm="."><plain>Aortic valve severity was determined by echocardiography </plain></SENT>
<SENT sid="3" pm="."><plain>Calcification and <z:mp ids='MP_0001845'>inflammation</z:mp> in the aortic valve were assessed by <z:chebi fb="0" ids="36939">18F</z:chebi>-<z:chebi fb="0" ids="28741">sodium fluoride</z:chebi> (<z:chebi fb="0" ids="36939">18F</z:chebi>-<z:chebi fb="0" ids="28741">NaF</z:chebi>) and <z:chebi fb="0" ids="49134">18F-fluorodeoxyglucose</z:chebi> (<z:chebi fb="0" ids="36939">18F</z:chebi>-FDG) uptake with the use of <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography </plain></SENT>
<SENT sid="4" pm="."><plain>One hundred twenty-one subjects (20 controls; 20 aortic <z:mp ids='MP_0000612'>sclerosis</z:mp>; 25 mild, 33 moderate, and 23 severe <z:hpo ids='HP_0001650'>aortic stenosis</z:hpo>) were administered both <z:chebi fb="0" ids="36939">18F</z:chebi>-<z:chebi fb="0" ids="28741">NaF</z:chebi> and <z:chebi fb="0" ids="36939">18F</z:chebi>-FDG </plain></SENT>
<SENT sid="5" pm="."><plain>Quantification of tracer uptake within the valve demonstrated excellent interobserver repeatability with no fixed or proportional biases and limits of agreement of ±0.21 (<z:chebi fb="0" ids="36939">18F</z:chebi>-<z:chebi fb="0" ids="28741">NaF</z:chebi>) and ±0.13 (<z:chebi fb="0" ids="36939">18F</z:chebi>-FDG) for maximum tissue-to-background ratios </plain></SENT>
<SENT sid="6" pm="."><plain>Activity of both tracers was higher in patients with <z:hpo ids='HP_0001650'>aortic stenosis</z:hpo> than in control subjects (<z:chebi fb="0" ids="36939">18F</z:chebi>-<z:chebi fb="0" ids="28741">NaF</z:chebi>: 2.87±0.82 versus 1.55±0.17; <z:chebi fb="0" ids="36939">18F</z:chebi>-FDG: 1.58±0.21 versus 1.30±0.13; both P&lt;0.001) </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="36939">18F</z:chebi>-<z:chebi fb="0" ids="28741">NaF</z:chebi> uptake displayed a progressive rise with valve severity (r(2)=0.540, P&lt;0.001), with a more modest increase observed for <z:chebi fb="0" ids="36939">18F</z:chebi>-FDG (r(2)=0.218, P&lt;0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>Among patients with <z:hpo ids='HP_0001650'>aortic stenosis</z:hpo>, 91% had increased <z:chebi fb="0" ids="36939">18F</z:chebi>-<z:chebi fb="0" ids="28741">NaF</z:chebi> uptake (&gt;1.97), and 35% had increased <z:chebi fb="0" ids="36939">18F</z:chebi>-FDG uptake (&gt;1.63) </plain></SENT>
<SENT sid="9" pm="."><plain>A weak correlation between the activities of these tracers was observed (r(2)=0.174, P&lt;0.001) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: <z:chebi fb="4" ids="30225">Positron</z:chebi> emission tomography is a novel, feasible, and repeatable approach to the evaluation of valvular calcification and <z:mp ids='MP_0001845'>inflammation</z:mp> in patients with <z:hpo ids='HP_0001650'>aortic stenosis</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>The frequency and magnitude of increased tracer activity correlate with disease severity and are strongest for <z:chebi fb="0" ids="36939">18F</z:chebi>-<z:chebi fb="0" ids="28741">NaF</z:chebi> </plain></SENT>
<SENT sid="12" pm="."><plain>CLINICAL TRIAL REGISTRATION: http://www.clinicaltrials.gov </plain></SENT>
<SENT sid="13" pm="."><plain>Unique identifier: NCT01358513 </plain></SENT>
</text></document>